| 标题 |
Combined treatment with anlotinib and chemotherapy for advanced esophageal squamous cell carcinoma improved patient survival: a case report
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Am J Transl Res 2020;12(10):6578-6583. PMID:33194054. Anlotinib (oral multi-target RTK TKI) + chemo 4th-line ESCC, survival >19mo. PMCID:PMC7653628 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)